Skip to main content
letter
. 2021 Feb 3;5(3):787–790. doi: 10.1182/bloodadvances.2020003806

Figure 1.

Figure 1.

Overall survival by days from diagnosis to treatment. (A) Grouping: 0-5 d vs 6-10 d vs 11-15 d vs >15 d. P < .0001. (B) Grouping: 0-1 d vs 2-3 d vs 4-6 d vs >6 d. P < .0001. DxTxGrp, grouping according to number of days from diagnosis to treatment.